Multidisciplinary management of adult anaplastic oligodendrogliomas and anaplastic mixed oligo-astrocytomas

Seminars in Radiation Oncology

Volumn 11, Issue 2, 2001, Pages 170-180

  Bauman, Glenn S ^a,b   Cairncross, J Gregory ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLINE; LOMUSTINE; MONOCLONAL ANTIBODY KI 67; PROCARBAZINE; VINCRISTINE;

ADULT; ASTHENIA; ASTROCYTOMA; BONE MARROW SUPPRESSION; CANCER GRADING; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; COMPUTER ASSISTED TOMOGRAPHY; GLIOBLASTOMA; HUMAN; MULTIMODALITY CANCER THERAPY; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROGNOSIS; RASH; REVIEW;

EID: 0035075382     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1053/srao.2001.21429     Document Type: Article

References (56)

1. Magnetic resonance features of the enigmatic oligodendroglioma
2. Oligodendrogliomas: Part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: A study of 153 cases
3. Oligodendrogloma: The Rotterdam-Dijkzigt experience
4. Prognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas: A study of 89 cases
5. Oligodendrogliomas. Part II: A new grading system based on morphology and imaging criteria
6. Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors
7. Pretreatment factors predict overall survival for patients with low grade glioma: A recursive partitioning analysis
8. Pathology and classification
9. Oligodendroglioma: Incidence and biological behaviour in a defined population
10. Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas
11. Prognostic relevance of TP53 mutations, P53 protein, Ki-67 index and conventional histological grading in oligodendroliomas
12. Prognostic factors in oligodendroglioma
13. A simplified classification of the gliomas
14. Grading of oligodendrogliomas
15. Grading of astrocytomas. A simple and reproducible method
16. Oligodendroglioma: A comparison of two grading systems
17. Oligodendrogliomas: The Mayo Clinic experience
18. Mixed oligoastrocytomas: A survival and prognostic factor analysis
19. Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: A report of radiation therapy oncology group 83-02
20. Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma
21. Procarbazine, lomustine and vincristine (PCV) chemotherapy for Grade III and Grade IV oligoastrocytoma
22. Alterations of chromosome arms lp and 19q as predictors of survival in oligodendrogliomas, astrocytomas and mixed oligoastrocytomas
23. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas
24. Malignant astrocytomas: Surgical aspects
25. The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas
26. A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844
27. Early postoperative magnetic resonance imaging after resection of malignant glioma: Objective evaluation of residual tumor and its influence on regrowth and prognosis
28. The role of tumor resection in the treatment of glioblastoma multiforme in adults
29. Cerebral oligodendroglioma: Prognostic factors and life history
30. Contemporary approaches to the treatment of malignant gliomas with radiation therapy
31. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas
32. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery
33. A randomized trial of accelerated hyperfractionated radiation therapy and bis-chlorethyl nitrosourea for malignant glioma
34. Long term results of RTOG 9006: A randomized trial of hyperfractionated radiotherapy (RT) to 72 Gy and carmustine vs standart RT & carmustine for malignant glioma patients with emphasis on apnaplastic astrocytoma (AA) patients, Proc of Am Soc Clin Oncol (ASCO). Los Angeles, CA
35. Accelerated radiotherapy in glioblastoma multiforme: A dose searching prospective study
36. A Prospective Randomized Trial of Low- Versus High-Dose Radiation Therapy in Adults with Supratentorial Low-Grade Glioma: Initial Report of a NCCTG-RTOG-ECOG Study
37. Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma
38. The treatment of anaplastic oliogdendrogliomas and mixed gliomas
39. Advantage of treating anaplastic gliomas with aggressive protocol combining chemotherapy and radiotherapy
40. Stereotactic histologic correlations of computed tomography and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms
41. The fallacy of the localized supratentorial malignant glioma
42. Assumptions in the radiotherapy of glioblastoma
43. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma
44. Modified procarbazine CCNU and vincristine (PCV-3) combination chemotherapy in the treatment of malignant brain tumors
45. Successful chemotherapy for recurrent malignant oligodendroglioma
46. Salvage chemotherapy for oligodendroglioma
47. Chemotherapy for anaplastic oligodendroglioma
48. Pre-radiation chemotherapy for malignant gliomas in adults
49. Combined treatment modality for anaplastic oliogodendroglioma: A Phase II Study
50. Clinical, pathological and therapeutic aspects of oligodendroglioma
51. Management of oligodendroliomas
52. Oligodendroglioma: The princess margaret hospital experience (1958-1984)
53. Radiation and chemotherapy improve outcome in oligodendroglioma
54. The treatment of cerebral oligodendrogliomas with particular reference to features indicating malignancy
55. Treatment of oligodendroglioma: An update